A multicenter randomized phase II/III trial of preoperative versus postoperative chemotherapy with XELOX plus bevacizumab in patients with resectable colorectal liver metastasis.

Trial Profile

A multicenter randomized phase II/III trial of preoperative versus postoperative chemotherapy with XELOX plus bevacizumab in patients with resectable colorectal liver metastasis.

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 24 Dec 2013

At a glance

  • Drugs Capecitabine (Primary) ; Oxaliplatin (Primary) ; Bevacizumab
  • Indications Adenocarcinoma; Liver metastases
  • Focus Therapeutic Use
  • Acronyms HiSCO-01
  • Most Recent Events

    • 10 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top